Categorías
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
22
Water Analysis
13
n-Butyllithium, 1.6M solution in Hexane
(90004726 | 109-72-8)
CAS: | 109-72-8 |
---|---|
Fórmula molecular: | C4H9 Li |
Peso molecular: | 64.06 |
Disponibilidad: | En stock |
---|---|
Descargas: | | |
Este producto está sujeto a un recargo peligroso. La cantidad exacta será confirmada por nuestro equipo de ventas.
90004726-100ml | 100ml | £50.00 | |
Pedido bulk |
90004726-100ml | 100ml | €70.00 | |
Pedido bulk |
90004726-100ml | 100ml | $75.00 | |
Pedido bulk |
Ficha de datos de seguridad
Certificado de análisis
Detalle del producto
Product Code | 90004726 | ||||
Product Name | n-Butyllithium, 1.6M solution in Hexane | ||||
Categories | Building Blocks Grignard Reagents | ||||
CAS | 109-72-8 | ||||
Molecular Formula | C4H9 Li | ||||
Molecular Weight | 64.06 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 29319000 |
Especificaciones del producto
Assay | 1.50M - 1.70M (14.0-16.0wt %.) | ||||
Form | Clear to hazy liquid- If precipitate is present, gently mix back into solution | ||||
Appearance | Colourless to yellow solution |
Información de seguridad
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|